We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PRSO:NASDAQPeraso Inc. Analysis

Data as of 2026-04-25 - not real-time

$1.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Peraso Inc. (PRSO) trades around $1.00, just above its 20‑day SMA (0.99) but below the 50‑ and 200‑day SMAs (≈1.07), indicating a neutral price stance. The RSI sits at 47 (neutral) and the MACD line, though still negative, has crossed above its signal, producing a small bullish histogram (+0.007) amid rising volume. Volatility is extreme (158% 30‑day) and beta is negative (‑0.38), while the stock has endured a steep max drawdown of ~65%, reflecting a high‑risk profile. Fundamentals are weak: revenue fell 22%, operating and profit margins are deep negative, EPS is –$0.67, and cash flow is negative, yet the price‑to‑sales ratio is modest (≈1.03) and analysts’ price targets imply a 181% upside, with the Fear & Greed Index flashing “Extreme Greed.”
Recent coverage labels PRSO as “Too Cheap To Ignore” and highlights an upcoming presentation at the Centri Capital Conference, suggesting short‑term catalyst potential. The company’s mmWave technology aligns with growing 5G and eVTOL markets, but the balance sheet shows limited cash (≈$2.9 M) against a high debt‑to‑equity ratio (≈4.1) and ongoing cash burn, underscoring the need for execution to realize the upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD crossover with rising volume
  • Price near support (≈$0.90) and resistance (≈$1.11)
  • Recent positive media attention

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets suggesting >180% upside
  • Potential demand growth in mmWave 5G and eVTOL applications
  • Technical neutral‑to‑bullish bias despite high volatility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic positioning in high‑growth mmWave market
  • Long‑run upside potential if cash burn is curbed and profitability improves
  • Extreme greed sentiment indicating market enthusiasm

Key Metrics & Analysis

Financial Health

Revenue Growth-22.00%
Profit Margin-38.98%
P/E Ratio-6.1
ROE-117.33%
ROA-46.89%
Debt/Equity4.14
P/B Ratio2.0
Op. Cash Flow$-5610000
Free Cash Flow$-4207000
Industry P/E38.1

Technical Analysis

TrendNeutral
RSI47.3
Support$0.90
Resistance$1.11
MA 20$0.99
MA 50$1.07
MA 200$1.07
MACDBullish
VolumeIncreasing
Fear & Greed Index88.02

Valuation

Target Price$2.82
Upside/Downside181.89%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta-0.38
Volatility158.37%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.